4SC broadens shareholder based with €12M fund raising
This article was originally published in Scrip
Executive Summary
4SC, the Munich-based biopharmaceutical company, was able to raise €12 million through the sale of 3.5 million shares at €3.40 in a private placement to institutional investors. The new funds, which will be used to finance existing clinical programmes, extend the company's financial runway from the end of 2011 to the end of 2012.